• Login
    Browsing 2 Conference Abstracts by Title 
    •   Home
    • 2 Conference Abstracts
    • Browsing 2 Conference Abstracts by Title
    •   Home
    • 2 Conference Abstracts
    • Browsing 2 Conference Abstracts by Title
    Mar 06, 2021
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of MSFTitleAuthorsSubjectsPublisherJournalThis CommunityTitleAuthorsSubjectsPublisherJournal

    Browsing 2 Conference Abstracts by Title

    • 0-9
    • A
    • B
    • C
    • D
    • E
    • F
    • G
    • H
    • I
    • J
    • K
    • L
    • M
    • N
    • O
    • P
    • Q
    • R
    • S
    • T
    • U
    • V
    • W
    • X
    • Y
    • Z

    xmlui.ArtifactBrowser.ConfigurableBrowse.view

    Sort by:

    Order:

    Results:

    Now showing items 63-82 of 127

    • List view
    • Grid view
    • title
    • issue date
    • submit date
    • ascending
    • descending
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
      • Thumbnail

        HAART can be provided safely in African HIV positive children: analysis of patients in 2 urban health centres in Kigali (Rwanda)

        De Naeyer, L; van Griensven, J; Ubarijoro, S; Mushi, T; Ntabashwa, G; Gazille, C; Zachariah, R (2006)
      • Thumbnail

        HIGH ACCEPTABILITY OF COTRIMOXAZOLE AND ANTIRETROVIRAL TREATMENT AMONG HIV INFECTED TUBERCULOSIS PATIENTS OFFERED INTEGRATE

        Telfer, B; Ombeka, V O; Zachariah, Rony; Van Engelgem, Ian; Kizito, W; Raguenaud, Marie-Eve; MSF Brussels (2008-03-19)
      • Thumbnail

        A high percentage of antiretroviral treatment-(ART) experienced patients enrolled in an HIV treatment program in Lagos, Nigeria: a comparison of the virological and immunological outcomes of ARV-naïve and ARV-experienced patients on 2003 WHO-recommended first-line ART

        Wenkel, J; O'Brien, Daniel P; Chan, K; Van den Boogaard, W; Botha Standaert, E; Braker, K; Olaiya, M; Guenther, G; Grillo, AG; Olomo, BA; et al. (2006)
      • Thumbnail

        HIV-positive migrants face important problems of access to care in Thailand

        Dahmane A; Caluwaerts A; Reid T (2009-07)
      • Thumbnail

        How common is Lipodystrophy after >1 year of WHO First Line Antiretroviral Treatment in Kigali, Rwanda?

        van Griensven, Johan; De Naeyer, Ludwig; Mushi, Thomas; Ubarijoro, Sowaf; Gazille, Claire; Zachariah, R; MSF OCB, Rwanda; Ministry of Health (2006)
      • Thumbnail

        How to implement infection control measures in the community: experience from the field

        Vincent-Smith, Robin (2008-10)
      • Thumbnail

        Human African Trypanosomiasis: Real Obstacles to Elimination

        Serge Kazadi, Michel Quere, Jacqueline Tong, Claude Mahoudeau, François Chappuis; Medecins Sans Fronteres (2009-11)
        Significant progress has been made in controlling human African trypanosomiasis (HAT) caused by T.b. gambiense as evidenced by the clear decline in the number of reported cases in recent years. Now the prevailing discourse is about the possible elimination of HAT and the need to integrate treatment for it into existing health structures. However, “Hot spots” still exist and one of which is the northeastern region of Orientale Province in the Democratic Republic of Congo (DRC). In this region there is neither a monitoring system nor working health centres capable of diagnosing and treating patients. An assessment carried out by the DRC’s national program to fight HAT and Doctors Without Borders/Médecins Sans Frontières (MSF) in 2004 discovered an alarming prevalence (2.1%) in the region. Between June 2007 and March 2009 MSF launched a HAT monitoring program in the Doruma, Ango, and Bili health zones. The overall prevalence was found to be 3.4%. Of the 46,601 people tested (18,559 through passive screening and 28,042 through active screening), 1,570 people were infected with T.b. gambiense. Of that group, 947 (60%) were in the first phase of HAT, indicating intense transmission of the disease. Due to the acute insecurity in this region of the DRC, MSF had to suspend its projects in March 2009, even though the limits of the disease foci had not yet been reached. Moreover, the disease could spread further by the displacement of entire populations who are fleeing the insecurity and heading for areas that had been previously “cleaned” of HAT. The intervention, which took place during a crisis situation, leads us to question the feasibility of eliminating HAT and integrating treatment in crisis areas where health services are at a minimum.
      • Thumbnail

        Immuno-virological and toxicity outcomes of HIV-infected patients after 48 months of ART in Phnom Penh, Cambodia

        Schramm, B; Balkan, Suna; Som, L; Nerreniet, D; Nget, CC; Moeung, S; Narom, P; Pinoges, Loretxu; Ferradini, Laurent; Pujades-Rodriguez, M (2008-08)
      • Thumbnail

        Implementation of Thin Layer Agar for Mycobacterium culture in rural Kenya

        MSF Kenya (2008-10)
      • Thumbnail

        Improving diagnosis and follow up of Multi-drug Resistant Tuberculosis at Primary Health Care level: the experience from Khayelitsha, Cape Town

        Goemaere, Eric; Sokhela, S; Siyolo, Z; Azevedo, V; Maas, C; Lotter, M; Hilderbrand, K; McDermid, C; MSF Brussels (2008-03-19)
      • Thumbnail

        Increased baseline body weight is a risk factor associated with virological failure while on antiretroviral treatment

        van Griensven, Johan; Rasschaert, F; Atte, E; Zachariah, R (2008-08)
      • Thumbnail

        The increasing burden of smear negative TB in high HIV prevalence settings – the case of Khayelitsha, Cape Town

        Azevedo, V; Ford, N; Mkoko, K.3; Zachariah, R; Hilderbrand, K; Goemaere, Eric; Sondlo, Z.2; Van Cutsem, G; Boulle, A; MSF Brussels (2008-03-19)
      • Thumbnail

        Is ALT control really necessary for routine ART monitoring in resource poor settings?

        di Mattei, P; Nguimfack, A; Sitoe, F; Gregorio, D; Toalha, B (2006)
      • Thumbnail

        Liquid culture. Practical challenges with MGIT

        Anandi, M (2008-10)
      • Thumbnail

        Low level of virological failure and drug resistance among patients receiving antiretroviral treatment under programme conditions in Maputo, Mozambique

        Maldonado, F; Biot, M; Roman, F; Masquelier, C; Anapenge, M; Bastos, R; Chuquela, H C; Arendt, V; Schmit, J C; Zachariah, R (2008-08)
      • Thumbnail

        Methodological issues raised from the coverage survey of the MSF nutritional programme. Madarounfa and Guidan Roumdji, Maradi region, Niger 2006.

        Nackers, Fabienne; Rehmet, Sybille; Defourny, Isabelle; Brown, Vincent; Grais, RFebecca F; Gaboulaud, Valérie (2007)
      • Thumbnail

        Molecular methods for TB drug resistance testing: What is needed: Experience from Khayelitsha

        Cox, Helen (2008-10)
      • Thumbnail

        MSF OCB Operational Research Day 2013

        MSF OCB LUXOR (2013-06)
      • Thumbnail

        MSF OCB Operational Research Day 2014

        MSF OCB (2014-06-23)
      • Thumbnail

        MSF OCB Operational Research Day 2016

        MSF OCB (2016-06)
        DSpace software (copyright © 2002 - 2021)  DuraSpace
        Quick Guide | Contact Us
        Open Repository is a service operated by 
        Atmire NV
         

        Export search results

        The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

        By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

        To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

        After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.